Table 2.
Univariate analysis of survival using Log-rank (Mantel-Cox) test
| Median survival (months) | Hazard ratio (95%CI) | p value | |
|---|---|---|---|
| Age (years) | |||
| <70 (N=40) | 156 | 0.50 (0.26-0.9) | 0.03 |
| ≥70 (N=37) | 24 | ||
| Sex | |||
| Male (N=50) | 57 | 0.91 (0.5-1.7) | 0.78 |
| Female (N =27) | 36 | ||
| Sites | |||
| Nodal (N =71) | 44 | 0.46 (0.1-1.7) | 0.25 |
| Extranodal (N =6) | 14 | ||
| History of CLL | |||
| Yes (N =44) | 57 | 1.1 (0.6-2.1) | 0.70 |
| No (N =33) | 44 | ||
| Morphological types | |||
| Type I (N =26) | 44 | 0.98 (0.5-1.9) | 0.95 |
| Type II (N =51) | 57 | ||
| EBV | |||
| Positive (N =55) | 57 | 0.9 (0.5-1.8) | 0.79 |
| Negative (N =22) | 28 | ||
| ZAP-70 | |||
| Positive (N =14) | 24 | 0.94 (0.4-2.1) | 0.89 |
| Negative (N =19) | 17 | ||
| Clonal relationship | |||
| Unrelated (N =19) | 24 | 0.68 (0.30-1.6) | 0.36 |
| Related (N =14) | 15 |